Log in to download the data
| Last Updated on PharmaCompass | Virtual Booth | Country | Holder | DMF No. | Subject | Submission Date | Status | Type | GDUFA DMF Review | GDUFA Review Date | GDUFA Payment Date |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 31/10/2025 | Johnson & Johnson Innovative Medicine |
U.S.A |
BASILEA PHARMACEUTICA INTERNATIONAL LTD | 20446 | CEFTOBIPROLE MEDOCARIL (R473928) DRUG SUBSTANCE | 2007-05-03 | Inactive | II | N/A |
